TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Human Protein Index Stirs NCI, NCAB Interest, Fires Up Growing Controversy August 7, 1981
TCL Archive In Brief: Hutchinson Awarded $8 Million Grant For Pancreatic, Colorectal Cancer Studies September 18, 1998
